Login to Your Account



Pharma: Clinic Roundup


Friday, March 23, 2012

• Almirall SA, of Barcelona, Spain, said the European Respiratory Journal published full results of ATTAIN (Aclidinium To Treat Airway obstruction In COPD patieNts), a six-month pivotal study comparing the efficacy and safety of twice-daily inhaled aclidinium (200 mcg and 400 mcg) against placebo in patients with moderate to severe chronic obstructive pulmonary disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription